Biolevate
Last verified 2026-05-17. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $6.5Mattributed |
|---|---|
| Latest round | seed, $6.5M, 2024-11-01attributed |
| Founded | 2022 |
| Headquarters | Paris, France |
| Industry | healthtech |
| Stage | seed |
| Website | biolevate.com |
AI knowledge platform for life-science teams covering literature review, documentation, and regulatory workflows. Built for pharma, biotech, and CRO researchers. 2.5x faster systematic literature reviews; positions knowledge as a governable operational system rather than chatbot output.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-11-01 | seed | $6.5M | undisclosed |
Detected tech stack
Amazon Web Services, reCAPTCHA, Google Tag Manager, Framer Sites, WordPress, React 16.13.1, PHP, MySQL
Provenance
| Fact | Status | Basis |
|---|---|---|
| Seed, $6.5M | attributed | eu-startups named as publisher. No document URL on file. |
| Total raised $6.5M | attributed | eu-startups named as publisher. No document URL on file. |
| Company existence | self-reported | biolevate.com, read 2026-05-17 |
| Description | self-reported | biolevate.com, read 2026-05-17 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.